An Open-label study of Mavrilimumab in Rheumatoid Arthritis

• Research type

  Research Study

• Full title

  An Open-label Extension Study to Evaluate the Long-term Safety of Mavrilimumab in Adult Subjects with Rheumatoid Arthritis Protocol Ref: CD-IA-CAM-3001-1109

• IRAS ID

  128448

• Contact name

  Andrew James Knowles Ostor

• Contact email

  andrew.ostor@addenbrookes.nhs.uk

• Sponsor organisation

  MedImmune Ltd

• Eudract number

  2011-005648-93

• ISRCTN Number

  n/a

• REC name

  East of England - Cambridge South Research Ethics Committee

• REC reference

  13/EE/0151

• Date of REC Opinion

  5 Jul 2013

• REC opinion

  Further Information Favourable Opinion